These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2469867

  • 1. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA, Murad F.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [Abstract] [Full Text] [Related]

  • 2. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F, Waldman S, Molina C, Bennett B, Leitman D.
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [Abstract] [Full Text] [Related]

  • 3. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS, Cantor E, Ho E, Walega M.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC, Murad F.
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [Abstract] [Full Text] [Related]

  • 5. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
    Rapoport RM, Murad F.
    J Cyclic Nucleotide Protein Phosphor Res; 1983 Mar; 9(4-5):281-96. PubMed ID: 6147363
    [Abstract] [Full Text] [Related]

  • 6. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]

  • 7. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [Abstract] [Full Text] [Related]

  • 8. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 9. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
    Ishii K, Chang B, Kerwin JF, Wagenaar FL, Huang ZJ, Murad F.
    J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
    [Abstract] [Full Text] [Related]

  • 10. Role of cyclic-GMP in relaxations of vascular smooth muscle.
    Murad F, Rapoport RM, Fiscus R.
    J Cardiovasc Pharmacol; 1985 Jan; 7 Suppl 3():S111-8. PubMed ID: 2409383
    [Abstract] [Full Text] [Related]

  • 11. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
    Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L.
    J Cyclic Nucleotide Res; 1979 Jan; 5(3):211-24. PubMed ID: 39089
    [Abstract] [Full Text] [Related]

  • 12. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor].
    Förstermann U.
    Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541
    [Abstract] [Full Text] [Related]

  • 13. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
    Kanamaru K, Waga S, Kojima T, Fujimoto K.
    No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
    [Abstract] [Full Text] [Related]

  • 14. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA, Tichotsky A, Muro M, Spaeth JP, Le Cras TD, Rengasamy A.
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [Abstract] [Full Text] [Related]

  • 15. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H, Yoshikawa T, Hisayama T, Takeuchi S.
    Eur J Pharmacol; 1992 Jan 07; 210(1):61-8. PubMed ID: 1350988
    [Abstract] [Full Text] [Related]

  • 16. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S, Bekker JM, Ovadia B, Stuart RB, Johengen MJ, Black SM, Fineman JR.
    J Thorac Cardiovasc Surg; 2004 May 07; 127(5):1285-92. PubMed ID: 15115984
    [Abstract] [Full Text] [Related]

  • 17. Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta.
    Rapoport RM, Murad F.
    Eur J Pharmacol; 1984 Sep 03; 104(1-2):61-70. PubMed ID: 6149944
    [Abstract] [Full Text] [Related]

  • 18. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium.
    Buhimschi IA, San Martin-Clark O, Aguan K, Thompson LP, Weiner CP.
    Am J Obstet Gynecol; 2000 Dec 03; 183(6):1512-9. PubMed ID: 11120520
    [Abstract] [Full Text] [Related]

  • 19. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A, Busse R, Bassenge E.
    Z Kardiol; 1989 Dec 03; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [Abstract] [Full Text] [Related]

  • 20. L-Citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation.
    Ruiz E, Del Rio M, Somoza B, Ganado P, Sanz M, Tejerina T.
    J Pharmacol Exp Ther; 1999 Jul 03; 290(1):310-3. PubMed ID: 10381792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.